NatureCell Co.Ltd
NatureCell Co.,Ltd. manufactures and sells canned and health functional food products, beverages, stem cell, and cosmetics in South Korea and internationally. The company's products comprise fruit drinks, aloe vera drinks, coffee, energy drinks, and Korean sauces, as well as offers domestic products and ETC products under the SAMMI and OEM brands. It also provides services for the preservation of… Read more
NatureCell Co.Ltd (007390) - Total Assets
Latest total assets as of September 2025: ₩71.32 Billion KRW
Based on the latest financial reports, NatureCell Co.Ltd (007390) holds total assets worth ₩71.32 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
NatureCell Co.Ltd - Total Assets Trend (2009–2024)
This chart illustrates how NatureCell Co.Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
NatureCell Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
NatureCell Co.Ltd's total assets of ₩71.32 Billion consist of 58.4% current assets and 41.6% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩28.37 Billion | 0.0% |
| Accounts Receivable | ₩9.50 Billion | 13.2% |
| Inventory | ₩2.97 Billion | 4.1% |
| Property, Plant & Equipment | ₩13.88 Billion | 19.3% |
| Intangible Assets | ₩1.54 Billion | 2.1% |
| Goodwill | ₩976.01 Million | 1.4% |
Asset Composition Trend (2009–2024)
This chart illustrates how NatureCell Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NatureCell Co.Ltd's current assets represent 58.4% of total assets in 2024, an increase from 0.0% in 2009.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 2.6% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2009.
- Asset Diversification: The largest asset category is cash and equivalents at 0.0% of total assets.
NatureCell Co.Ltd Competitors by Total Assets
Key competitors of NatureCell Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
AGP Ltd
KAR:AGP
|
Pakistan | PKRs28.27 Billion |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩529.96 Billion |
|
DongKoo Bio&Pharma Co. Ltd
KQ:006620
|
Korea | ₩269.00 Billion |
|
Sam-A Pharm. Co. Ltd
KQ:009300
|
Korea | ₩246.13 Billion |
|
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040
|
Korea | ₩291.47 Billion |
|
WooGene B&G Co. Ltd
KQ:018620
|
Korea | ₩117.10 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩154.14 Billion |
|
EstechPharma Co. Ltd
KQ:041910
|
Korea | ₩192.01 Billion |
NatureCell Co.Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - NatureCell Co.Ltd generates 0.45x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, NatureCell Co.Ltd generates $ 1.70 in net profit.
NatureCell Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.91 | 10.48 | 2.75 |
| Quick Ratio | 7.61 | 9.56 | 2.59 |
| Cash Ratio | 0.00 | 6.37 | 0.00 |
| Working Capital | ₩35.05 Billion | ₩ 36.95 Billion | ₩ 35.82 Billion |
NatureCell Co.Ltd - Advanced Valuation Insights
This section examines the relationship between NatureCell Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 20.39 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 5.3% |
| Total Assets | ₩72.00 Billion |
| Market Capitalization | $37.82 Million USD |
Valuation Analysis
Below Book Valuation: The market values NatureCell Co.Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: NatureCell Co.Ltd's assets grew by 5.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for NatureCell Co.Ltd (2009–2024)
The table below shows the annual total assets of NatureCell Co.Ltd from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩72.00 Billion | +5.26% |
| 2023-12-31 | ₩68.40 Billion | -27.25% |
| 2022-12-31 | ₩94.02 Billion | +34.99% |
| 2021-12-31 | ₩69.65 Billion | -18.78% |
| 2020-12-31 | ₩85.75 Billion | -7.91% |
| 2019-12-31 | ₩93.11 Billion | +76.09% |
| 2018-12-31 | ₩52.88 Billion | +2.79% |
| 2017-12-31 | ₩51.44 Billion | -2.33% |
| 2016-12-31 | ₩52.67 Billion | +14.57% |
| 2015-12-31 | ₩45.97 Billion | +87.35% |
| 2014-12-31 | ₩24.54 Billion | +8.09% |
| 2010-12-31 | ₩22.70 Billion | -20.58% |
| 2009-12-31 | ₩28.58 Billion | -- |